nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ABCB1—breast cancer	0.223	1	CbGaD
Lisinopril—ABCB1—Toremifene—breast cancer	0.0671	0.223	CbGbCtD
Lisinopril—ABCB1—Lapatinib—breast cancer	0.049	0.162	CbGbCtD
Lisinopril—ABCB1—Vinorelbine—breast cancer	0.0272	0.0901	CbGbCtD
Lisinopril—ABCB1—Tamoxifen—breast cancer	0.0245	0.0813	CbGbCtD
Lisinopril—ABCB1—Mitoxantrone—breast cancer	0.0239	0.0793	CbGbCtD
Lisinopril—ABCB1—Gemcitabine—breast cancer	0.0211	0.0701	CbGbCtD
Lisinopril—ABCB1—Paclitaxel—breast cancer	0.0191	0.0633	CbGbCtD
Lisinopril—ABCB1—Irinotecan—breast cancer	0.0188	0.0624	CbGbCtD
Lisinopril—ABCB1—Vinblastine—breast cancer	0.0167	0.0555	CbGbCtD
Lisinopril—ABCB1—Docetaxel—breast cancer	0.0138	0.0458	CbGbCtD
Lisinopril—ABCB1—Doxorubicin—breast cancer	0.0103	0.0341	CbGbCtD
Lisinopril—ABCB1—Methotrexate—breast cancer	0.00996	0.033	CbGbCtD
Lisinopril—ACE—umbilical vein—breast cancer	0.00681	0.137	CbGeAlD
Lisinopril—ACE—arm—breast cancer	0.00595	0.12	CbGeAlD
Lisinopril—ACE2—adipose tissue—breast cancer	0.00358	0.0719	CbGeAlD
Lisinopril—ACE2—female reproductive system—breast cancer	0.00329	0.0661	CbGeAlD
Lisinopril—ACE2—female gonad—breast cancer	0.00299	0.0601	CbGeAlD
Lisinopril—ACE2—endocrine gland—breast cancer	0.00279	0.0559	CbGeAlD
Lisinopril—SLC15A1—epithelium—breast cancer	0.00202	0.0406	CbGeAlD
Lisinopril—ACE2—lymph node—breast cancer	0.00193	0.0387	CbGeAlD
Lisinopril—SLC15A1—endometrium—breast cancer	0.00181	0.0364	CbGeAlD
Lisinopril—ACE—embryo—breast cancer	0.00177	0.0356	CbGeAlD
Lisinopril—ACE—epithelium—breast cancer	0.00145	0.0291	CbGeAlD
Lisinopril—ACE—endometrium—breast cancer	0.0013	0.0261	CbGeAlD
Lisinopril—SLC15A1—endocrine gland—breast cancer	0.00127	0.0255	CbGeAlD
Lisinopril—ACE—pituitary gland—breast cancer	0.00118	0.0236	CbGeAlD
Lisinopril—ACE—adipose tissue—breast cancer	0.00117	0.0235	CbGeAlD
Lisinopril—ACE—female reproductive system—breast cancer	0.00108	0.0216	CbGeAlD
Lisinopril—ACE—adrenal gland—breast cancer	0.00105	0.0211	CbGeAlD
Lisinopril—ACE—bone marrow—breast cancer	0.00102	0.0204	CbGeAlD
Lisinopril—ACE—female gonad—breast cancer	0.000979	0.0197	CbGeAlD
Lisinopril—ACE—endocrine gland—breast cancer	0.000911	0.0183	CbGeAlD
Lisinopril—ACE—lymph node—breast cancer	0.000629	0.0126	CbGeAlD
Lisinopril—ABCB1—embryo—breast cancer	0.000625	0.0125	CbGeAlD
Lisinopril—Benazepril—MTHFR—breast cancer	0.000618	0.256	CrCbGaD
Lisinopril—Ramipril—BCHE—breast cancer	0.000559	0.232	CrCbGaD
Lisinopril—ABCB1—epithelium—breast cancer	0.00051	0.0102	CbGeAlD
Lisinopril—ABCB1—endometrium—breast cancer	0.000457	0.00918	CbGeAlD
Lisinopril—ABCB1—uterus—breast cancer	0.000421	0.00846	CbGeAlD
Lisinopril—ABCB1—pituitary gland—breast cancer	0.000414	0.00831	CbGeAlD
Lisinopril—ABCB1—adipose tissue—breast cancer	0.000412	0.00828	CbGeAlD
Lisinopril—ABCB1—female reproductive system—breast cancer	0.000379	0.00761	CbGeAlD
Lisinopril—ABCB1—adrenal gland—breast cancer	0.00037	0.00742	CbGeAlD
Lisinopril—ABCB1—bone marrow—breast cancer	0.000358	0.00718	CbGeAlD
Lisinopril—ABCB1—female gonad—breast cancer	0.000345	0.00692	CbGeAlD
Lisinopril—ABCB1—endocrine gland—breast cancer	0.000321	0.00644	CbGeAlD
Lisinopril—Nateglinide—PTGS1—breast cancer	0.000233	0.0966	CrCbGaD
Lisinopril—Cilazapril—ABCB1—breast cancer	0.000226	0.0937	CrCbGaD
Lisinopril—ABCB1—lymph node—breast cancer	0.000222	0.00445	CbGeAlD
Lisinopril—Enalapril—CYP3A4—breast cancer	0.0002	0.0826	CrCbGaD
Lisinopril—Enalapril—ABCB1—breast cancer	0.000166	0.0687	CrCbGaD
Lisinopril—Nateglinide—CYP2D6—breast cancer	0.000159	0.0657	CrCbGaD
Lisinopril—Nateglinide—CYP3A4—breast cancer	0.000136	0.0564	CrCbGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000132	0.0014	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—RPS8—breast cancer	0.000131	0.00139	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—RPS7—breast cancer	0.000131	0.00139	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—GZMB—breast cancer	0.00013	0.00138	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—breast cancer	0.000127	0.00135	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000125	0.00133	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—CXCR4—breast cancer	0.000124	0.00132	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—CXCL12—breast cancer	0.000124	0.00132	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—breast cancer	0.000123	0.0013	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000121	0.00128	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000121	0.00128	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CASP7—breast cancer	0.000119	0.00126	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—IGFBP3—breast cancer	0.000119	0.00126	CbGpPWpGaD
Lisinopril—Nateglinide—ALB—breast cancer	0.000119	0.0492	CrCbGaD
Lisinopril—ACE—Metabolism of proteins—ACHE—breast cancer	0.000116	0.00123	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—IGF1—breast cancer	0.000113	0.00119	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000112	0.00119	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NCOA1—breast cancer	0.000112	0.00119	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CTSD—breast cancer	0.00011	0.00117	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—MMP2—breast cancer	0.000109	0.00116	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—THBS1—breast cancer	0.000108	0.00115	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CXCL12—breast cancer	0.000107	0.00114	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CD40—breast cancer	0.000106	0.00113	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CTLA4—breast cancer	0.000105	0.00111	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—breast cancer	0.000103	0.00109	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—BCHE—breast cancer	0.000101	0.00107	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—breast cancer	0.000101	0.00107	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—HMOX1—breast cancer	0.000101	0.00107	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—RPS6—breast cancer	9.88e-05	0.00105	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—AGTR1—breast cancer	9.72e-05	0.00103	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—SMAD4—breast cancer	9.68e-05	0.00103	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—TUBB3—breast cancer	9.55e-05	0.00101	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—TCF7L2—breast cancer	9.42e-05	0.000999	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CXCL8—breast cancer	9.06e-05	0.000961	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—breast cancer	8.86e-05	0.000939	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—PLAUR—breast cancer	8.81e-05	0.000934	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MRE11A—breast cancer	8.75e-05	0.000928	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—PLG—breast cancer	8.61e-05	0.000913	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FST—breast cancer	8.53e-05	0.000904	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CTNNB1—breast cancer	8.36e-05	0.000887	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—TERT—breast cancer	8.29e-05	0.000879	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	7.95e-05	0.000843	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—breast cancer	7.92e-05	0.00084	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCG2—breast cancer	7.79e-05	0.000826	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC28A1—breast cancer	7.78e-05	0.000825	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—LEP—breast cancer	7.73e-05	0.00082	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—breast cancer	7.44e-05	0.000789	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—breast cancer	7.25e-05	0.000769	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NOS2—breast cancer	7.21e-05	0.000764	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC2A10—breast cancer	7.11e-05	0.000754	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC4A7—breast cancer	7.11e-05	0.000754	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—TFRC—breast cancer	6.94e-05	0.000736	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—breast cancer	6.77e-05	0.000718	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—NCOA2—breast cancer	6.68e-05	0.000709	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—FOS—breast cancer	6.66e-05	0.000706	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—breast cancer	6.5e-05	0.00069	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—breast cancer	6.46e-05	0.000685	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	6.37e-05	0.000676	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—breast cancer	6.37e-05	0.000675	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—breast cancer	6.31e-05	0.000669	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—MMP1—breast cancer	6.29e-05	0.000667	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	6.16e-05	0.000653	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—LEP—breast cancer	6.09e-05	0.000646	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—breast cancer	6.07e-05	0.000644	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—ALB—breast cancer	5.98e-05	0.000634	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—breast cancer	5.91e-05	0.000627	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC39A7—breast cancer	5.9e-05	0.000625	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—COX11—breast cancer	5.9e-05	0.000625	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—THBS1—breast cancer	5.88e-05	0.000624	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—breast cancer	5.88e-05	0.000624	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—NCOA1—breast cancer	5.63e-05	0.000597	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CASP8—breast cancer	5.63e-05	0.000597	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—breast cancer	5.61e-05	0.000595	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—PLG—breast cancer	5.49e-05	0.000582	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC22A18—breast cancer	5.39e-05	0.000572	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—breast cancer	5.2e-05	0.000552	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—breast cancer	5.2e-05	0.000552	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC2A5—breast cancer	5.19e-05	0.00055	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	5.19e-05	0.00055	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—HMOX1—breast cancer	5.06e-05	0.000537	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—breast cancer	5.04e-05	0.000535	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—IGF1—breast cancer	5.03e-05	0.000534	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—breast cancer	4.87e-05	0.000517	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—MMP2—breast cancer	4.87e-05	0.000516	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—breast cancer	4.87e-05	0.000516	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCB1—breast cancer	4.86e-05	0.000515	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IFNG—breast cancer	4.79e-05	0.000508	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—JUN—breast cancer	4.78e-05	0.000507	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—breast cancer	4.73e-05	0.000501	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—breast cancer	4.73e-05	0.000501	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—AR—breast cancer	4.6e-05	0.000487	CbGpPWpGaD
Lisinopril—Insomnia—Capecitabine—breast cancer	4.56e-05	0.000138	CcSEcCtD
Lisinopril—Rash—Fluorouracil—breast cancer	4.55e-05	0.000138	CcSEcCtD
Lisinopril—Dermatitis—Fluorouracil—breast cancer	4.54e-05	0.000138	CcSEcCtD
Lisinopril—Pharyngitis—Doxorubicin—breast cancer	4.54e-05	0.000138	CcSEcCtD
Lisinopril—Paraesthesia—Capecitabine—breast cancer	4.52e-05	0.000137	CcSEcCtD
Lisinopril—Decreased appetite—Docetaxel—breast cancer	4.52e-05	0.000137	CcSEcCtD
Lisinopril—Hypersensitivity—Paclitaxel—breast cancer	4.52e-05	0.000137	CcSEcCtD
Lisinopril—Headache—Fluorouracil—breast cancer	4.52e-05	0.000137	CcSEcCtD
Lisinopril—Urinary tract disorder—Doxorubicin—breast cancer	4.51e-05	0.000137	CcSEcCtD
Lisinopril—Oedema peripheral—Doxorubicin—breast cancer	4.5e-05	0.000137	CcSEcCtD
Lisinopril—Dysgeusia—Methotrexate—breast cancer	4.5e-05	0.000137	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Docetaxel—breast cancer	4.49e-05	0.000136	CcSEcCtD
Lisinopril—Dyspnoea—Capecitabine—breast cancer	4.49e-05	0.000136	CcSEcCtD
Lisinopril—Fatigue—Docetaxel—breast cancer	4.49e-05	0.000136	CcSEcCtD
Lisinopril—Angiopathy—Epirubicin—breast cancer	4.48e-05	0.000136	CcSEcCtD
Lisinopril—Urethral disorder—Doxorubicin—breast cancer	4.48e-05	0.000136	CcSEcCtD
Lisinopril—Nausea—Mitoxantrone—breast cancer	4.47e-05	0.000136	CcSEcCtD
Lisinopril—Nausea—Irinotecan—breast cancer	4.47e-05	0.000136	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC39A6—breast cancer	4.47e-05	0.000474	CbGpPWpGaD
Lisinopril—Mediastinal disorder—Epirubicin—breast cancer	4.45e-05	0.000135	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CXCL8—breast cancer	4.45e-05	0.000472	CbGpPWpGaD
Lisinopril—Pain—Docetaxel—breast cancer	4.45e-05	0.000135	CcSEcCtD
Lisinopril—Constipation—Docetaxel—breast cancer	4.45e-05	0.000135	CcSEcCtD
Lisinopril—Back pain—Methotrexate—breast cancer	4.45e-05	0.000135	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—breast cancer	4.44e-05	0.00047	CbGpPWpGaD
Lisinopril—Dyspepsia—Capecitabine—breast cancer	4.44e-05	0.000135	CcSEcCtD
Lisinopril—Chills—Epirubicin—breast cancer	4.43e-05	0.000135	CcSEcCtD
Lisinopril—Arrhythmia—Epirubicin—breast cancer	4.41e-05	0.000134	CcSEcCtD
Lisinopril—Asthenia—Paclitaxel—breast cancer	4.41e-05	0.000134	CcSEcCtD
Lisinopril—Decreased appetite—Capecitabine—breast cancer	4.38e-05	0.000133	CcSEcCtD
Lisinopril—Alopecia—Epirubicin—breast cancer	4.37e-05	0.000133	CcSEcCtD
Lisinopril—Nausea—Gemcitabine—breast cancer	4.36e-05	0.000132	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Capecitabine—breast cancer	4.35e-05	0.000132	CcSEcCtD
Lisinopril—Fatigue—Capecitabine—breast cancer	4.34e-05	0.000132	CcSEcCtD
Lisinopril—Pruritus—Paclitaxel—breast cancer	4.34e-05	0.000132	CcSEcCtD
Lisinopril—Vision blurred—Methotrexate—breast cancer	4.33e-05	0.000132	CcSEcCtD
Lisinopril—Mental disorder—Epirubicin—breast cancer	4.33e-05	0.000131	CcSEcCtD
Lisinopril—Erythema multiforme—Doxorubicin—breast cancer	4.32e-05	0.000131	CcSEcCtD
Lisinopril—Constipation—Capecitabine—breast cancer	4.31e-05	0.000131	CcSEcCtD
Lisinopril—Pain—Capecitabine—breast cancer	4.31e-05	0.000131	CcSEcCtD
Lisinopril—Malnutrition—Epirubicin—breast cancer	4.3e-05	0.000131	CcSEcCtD
Lisinopril—Erythema—Epirubicin—breast cancer	4.3e-05	0.000131	CcSEcCtD
Lisinopril—Feeling abnormal—Docetaxel—breast cancer	4.29e-05	0.00013	CcSEcCtD
Lisinopril—Nausea—Fluorouracil—breast cancer	4.28e-05	0.00013	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—breast cancer	4.27e-05	0.000453	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—breast cancer	4.27e-05	0.000453	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—breast cancer	4.27e-05	0.000453	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL1B—breast cancer	4.27e-05	0.000453	CbGpPWpGaD
Lisinopril—Ill-defined disorder—Methotrexate—breast cancer	4.26e-05	0.00013	CcSEcCtD
Lisinopril—Tinnitus—Doxorubicin—breast cancer	4.26e-05	0.000129	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CASP3—breast cancer	4.26e-05	0.000452	CbGpPWpGaD
Lisinopril—Gastrointestinal pain—Docetaxel—breast cancer	4.26e-05	0.000129	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL2—breast cancer	4.25e-05	0.000451	CbGpPWpGaD
Lisinopril—Anaemia—Methotrexate—breast cancer	4.25e-05	0.000129	CcSEcCtD
Lisinopril—Flushing—Doxorubicin—breast cancer	4.24e-05	0.000129	CcSEcCtD
Lisinopril—Flatulence—Epirubicin—breast cancer	4.24e-05	0.000129	CcSEcCtD
Lisinopril—Tension—Epirubicin—breast cancer	4.22e-05	0.000128	CcSEcCtD
Lisinopril—Dysgeusia—Epirubicin—breast cancer	4.21e-05	0.000128	CcSEcCtD
Lisinopril—Diarrhoea—Paclitaxel—breast cancer	4.2e-05	0.000128	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—breast cancer	4.19e-05	0.000444	CbGpPWpGaD
Lisinopril—Nervousness—Epirubicin—breast cancer	4.18e-05	0.000127	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—breast cancer	4.17e-05	0.000443	CbGpPWpGaD
Lisinopril—Back pain—Epirubicin—breast cancer	4.16e-05	0.000126	CcSEcCtD
Lisinopril—Feeling abnormal—Capecitabine—breast cancer	4.15e-05	0.000126	CcSEcCtD
Lisinopril—Angiopathy—Doxorubicin—breast cancer	4.15e-05	0.000126	CcSEcCtD
Lisinopril—Malaise—Methotrexate—breast cancer	4.14e-05	0.000126	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—breast cancer	4.14e-05	0.000439	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—breast cancer	4.14e-05	0.000439	CbGpPWpGaD
Lisinopril—Muscle spasms—Epirubicin—breast cancer	4.13e-05	0.000126	CcSEcCtD
Lisinopril—Vertigo—Methotrexate—breast cancer	4.13e-05	0.000125	CcSEcCtD
Lisinopril—Gastrointestinal pain—Capecitabine—breast cancer	4.12e-05	0.000125	CcSEcCtD
Lisinopril—Mediastinal disorder—Doxorubicin—breast cancer	4.12e-05	0.000125	CcSEcCtD
Lisinopril—Body temperature increased—Docetaxel—breast cancer	4.11e-05	0.000125	CcSEcCtD
Lisinopril—Abdominal pain—Docetaxel—breast cancer	4.11e-05	0.000125	CcSEcCtD
Lisinopril—Leukopenia—Methotrexate—breast cancer	4.11e-05	0.000125	CcSEcCtD
Lisinopril—Chills—Doxorubicin—breast cancer	4.1e-05	0.000125	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ATP7B—breast cancer	4.09e-05	0.000433	CbGpPWpGaD
Lisinopril—Arrhythmia—Doxorubicin—breast cancer	4.08e-05	0.000124	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—breast cancer	4.06e-05	0.000431	CbGpPWpGaD
Lisinopril—Dizziness—Paclitaxel—breast cancer	4.06e-05	0.000123	CcSEcCtD
Lisinopril—Vision blurred—Epirubicin—breast cancer	4.05e-05	0.000123	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—CXCL8—breast cancer	4.05e-05	0.000429	CbGpPWpGaD
Lisinopril—Alopecia—Doxorubicin—breast cancer	4.04e-05	0.000123	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—breast cancer	4.02e-05	0.000426	CbGpPWpGaD
Lisinopril—Cough—Methotrexate—breast cancer	4.01e-05	0.000122	CcSEcCtD
Lisinopril—Mental disorder—Doxorubicin—breast cancer	4e-05	0.000122	CcSEcCtD
Lisinopril—Urticaria—Capecitabine—breast cancer	4e-05	0.000122	CcSEcCtD
Lisinopril—Ill-defined disorder—Epirubicin—breast cancer	3.99e-05	0.000121	CcSEcCtD
Lisinopril—Abdominal pain—Capecitabine—breast cancer	3.98e-05	0.000121	CcSEcCtD
Lisinopril—Body temperature increased—Capecitabine—breast cancer	3.98e-05	0.000121	CcSEcCtD
Lisinopril—Malnutrition—Doxorubicin—breast cancer	3.98e-05	0.000121	CcSEcCtD
Lisinopril—Erythema—Doxorubicin—breast cancer	3.98e-05	0.000121	CcSEcCtD
Lisinopril—Anaemia—Epirubicin—breast cancer	3.98e-05	0.000121	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—breast cancer	3.97e-05	0.000421	CbGpPWpGaD
Lisinopril—Flatulence—Doxorubicin—breast cancer	3.92e-05	0.000119	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—breast cancer	3.92e-05	0.000415	CbGpPWpGaD
Lisinopril—Chest pain—Methotrexate—breast cancer	3.91e-05	0.000119	CcSEcCtD
Lisinopril—Arthralgia—Methotrexate—breast cancer	3.91e-05	0.000119	CcSEcCtD
Lisinopril—Myalgia—Methotrexate—breast cancer	3.91e-05	0.000119	CcSEcCtD
Lisinopril—Tension—Doxorubicin—breast cancer	3.91e-05	0.000119	CcSEcCtD
Lisinopril—Vomiting—Paclitaxel—breast cancer	3.9e-05	0.000119	CcSEcCtD
Lisinopril—Dysgeusia—Doxorubicin—breast cancer	3.9e-05	0.000118	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—breast cancer	3.89e-05	0.000412	CbGpPWpGaD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.89e-05	0.000118	CcSEcCtD
Lisinopril—Malaise—Epirubicin—breast cancer	3.88e-05	0.000118	CcSEcCtD
Lisinopril—Rash—Paclitaxel—breast cancer	3.87e-05	0.000118	CcSEcCtD
Lisinopril—Dermatitis—Paclitaxel—breast cancer	3.87e-05	0.000117	CcSEcCtD
Lisinopril—Discomfort—Methotrexate—breast cancer	3.87e-05	0.000117	CcSEcCtD
Lisinopril—Nervousness—Doxorubicin—breast cancer	3.87e-05	0.000117	CcSEcCtD
Lisinopril—Vertigo—Epirubicin—breast cancer	3.86e-05	0.000117	CcSEcCtD
Lisinopril—Syncope—Epirubicin—breast cancer	3.86e-05	0.000117	CcSEcCtD
Lisinopril—Leukopenia—Epirubicin—breast cancer	3.85e-05	0.000117	CcSEcCtD
Lisinopril—Back pain—Doxorubicin—breast cancer	3.85e-05	0.000117	CcSEcCtD
Lisinopril—Headache—Paclitaxel—breast cancer	3.85e-05	0.000117	CcSEcCtD
Lisinopril—Hypersensitivity—Docetaxel—breast cancer	3.83e-05	0.000116	CcSEcCtD
Lisinopril—Muscle spasms—Doxorubicin—breast cancer	3.83e-05	0.000116	CcSEcCtD
Lisinopril—Palpitations—Epirubicin—breast cancer	3.8e-05	0.000115	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ABCC1—breast cancer	3.8e-05	0.000403	CbGpPWpGaD
Lisinopril—Confusional state—Methotrexate—breast cancer	3.78e-05	0.000115	CcSEcCtD
Lisinopril—Loss of consciousness—Epirubicin—breast cancer	3.78e-05	0.000115	CcSEcCtD
Lisinopril—Cough—Epirubicin—breast cancer	3.75e-05	0.000114	CcSEcCtD
Lisinopril—Anaphylactic shock—Methotrexate—breast cancer	3.75e-05	0.000114	CcSEcCtD
Lisinopril—Vision blurred—Doxorubicin—breast cancer	3.75e-05	0.000114	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—CTNNB1—breast cancer	3.73e-05	0.000396	CbGpPWpGaD
Lisinopril—Asthenia—Docetaxel—breast cancer	3.73e-05	0.000113	CcSEcCtD
Lisinopril—Infection—Methotrexate—breast cancer	3.73e-05	0.000113	CcSEcCtD
Lisinopril—Hypersensitivity—Capecitabine—breast cancer	3.71e-05	0.000113	CcSEcCtD
Lisinopril—Ill-defined disorder—Doxorubicin—breast cancer	3.69e-05	0.000112	CcSEcCtD
Lisinopril—Pruritus—Docetaxel—breast cancer	3.68e-05	0.000112	CcSEcCtD
Lisinopril—Anaemia—Doxorubicin—breast cancer	3.68e-05	0.000112	CcSEcCtD
Lisinopril—Thrombocytopenia—Methotrexate—breast cancer	3.67e-05	0.000112	CcSEcCtD
Lisinopril—Myalgia—Epirubicin—breast cancer	3.66e-05	0.000111	CcSEcCtD
Lisinopril—Chest pain—Epirubicin—breast cancer	3.66e-05	0.000111	CcSEcCtD
Lisinopril—Arthralgia—Epirubicin—breast cancer	3.66e-05	0.000111	CcSEcCtD
Lisinopril—Anxiety—Epirubicin—breast cancer	3.65e-05	0.000111	CcSEcCtD
Lisinopril—Nausea—Paclitaxel—breast cancer	3.65e-05	0.000111	CcSEcCtD
Lisinopril—Skin disorder—Methotrexate—breast cancer	3.64e-05	0.000111	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.64e-05	0.00011	CcSEcCtD
Lisinopril—Hyperhidrosis—Methotrexate—breast cancer	3.63e-05	0.00011	CcSEcCtD
Lisinopril—Discomfort—Epirubicin—breast cancer	3.62e-05	0.00011	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—VEGFA—breast cancer	3.62e-05	0.000383	CbGpPWpGaD
Lisinopril—Asthenia—Capecitabine—breast cancer	3.61e-05	0.00011	CcSEcCtD
Lisinopril—Malaise—Doxorubicin—breast cancer	3.59e-05	0.000109	CcSEcCtD
Lisinopril—Dry mouth—Epirubicin—breast cancer	3.58e-05	0.000109	CcSEcCtD
Lisinopril—Vertigo—Doxorubicin—breast cancer	3.58e-05	0.000109	CcSEcCtD
Lisinopril—Anorexia—Methotrexate—breast cancer	3.58e-05	0.000109	CcSEcCtD
Lisinopril—Syncope—Doxorubicin—breast cancer	3.57e-05	0.000108	CcSEcCtD
Lisinopril—Pruritus—Capecitabine—breast cancer	3.56e-05	0.000108	CcSEcCtD
Lisinopril—Leukopenia—Doxorubicin—breast cancer	3.56e-05	0.000108	CcSEcCtD
Lisinopril—Diarrhoea—Docetaxel—breast cancer	3.56e-05	0.000108	CcSEcCtD
Lisinopril—Confusional state—Epirubicin—breast cancer	3.54e-05	0.000108	CcSEcCtD
Lisinopril—Palpitations—Doxorubicin—breast cancer	3.52e-05	0.000107	CcSEcCtD
Lisinopril—Anaphylactic shock—Epirubicin—breast cancer	3.51e-05	0.000107	CcSEcCtD
Lisinopril—Oedema—Epirubicin—breast cancer	3.51e-05	0.000107	CcSEcCtD
Lisinopril—Hypotension—Methotrexate—breast cancer	3.5e-05	0.000106	CcSEcCtD
Lisinopril—Loss of consciousness—Doxorubicin—breast cancer	3.5e-05	0.000106	CcSEcCtD
Lisinopril—Infection—Epirubicin—breast cancer	3.49e-05	0.000106	CcSEcCtD
Lisinopril—Cough—Doxorubicin—breast cancer	3.47e-05	0.000105	CcSEcCtD
Lisinopril—Shock—Epirubicin—breast cancer	3.45e-05	0.000105	CcSEcCtD
Lisinopril—Diarrhoea—Capecitabine—breast cancer	3.45e-05	0.000105	CcSEcCtD
Lisinopril—Dizziness—Docetaxel—breast cancer	3.44e-05	0.000105	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—breast cancer	3.44e-05	0.000365	CbGpPWpGaD
Lisinopril—Thrombocytopenia—Epirubicin—breast cancer	3.44e-05	0.000104	CcSEcCtD
Lisinopril—Tachycardia—Epirubicin—breast cancer	3.43e-05	0.000104	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Methotrexate—breast cancer	3.42e-05	0.000104	CcSEcCtD
Lisinopril—Skin disorder—Epirubicin—breast cancer	3.41e-05	0.000104	CcSEcCtD
Lisinopril—Hyperhidrosis—Epirubicin—breast cancer	3.39e-05	0.000103	CcSEcCtD
Lisinopril—Insomnia—Methotrexate—breast cancer	3.39e-05	0.000103	CcSEcCtD
Lisinopril—Chest pain—Doxorubicin—breast cancer	3.39e-05	0.000103	CcSEcCtD
Lisinopril—Arthralgia—Doxorubicin—breast cancer	3.39e-05	0.000103	CcSEcCtD
Lisinopril—Myalgia—Doxorubicin—breast cancer	3.39e-05	0.000103	CcSEcCtD
Lisinopril—Anxiety—Doxorubicin—breast cancer	3.38e-05	0.000103	CcSEcCtD
Lisinopril—Paraesthesia—Methotrexate—breast cancer	3.37e-05	0.000102	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.36e-05	0.000102	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—breast cancer	3.35e-05	0.000356	CbGpPWpGaD
Lisinopril—Discomfort—Doxorubicin—breast cancer	3.35e-05	0.000102	CcSEcCtD
Lisinopril—Anorexia—Epirubicin—breast cancer	3.35e-05	0.000102	CcSEcCtD
Lisinopril—Dyspnoea—Methotrexate—breast cancer	3.34e-05	0.000102	CcSEcCtD
Lisinopril—Somnolence—Methotrexate—breast cancer	3.33e-05	0.000101	CcSEcCtD
Lisinopril—ABCB1—Metabolism—SYNJ2—breast cancer	3.33e-05	0.000353	CbGpPWpGaD
Lisinopril—Dizziness—Capecitabine—breast cancer	3.33e-05	0.000101	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—TGFB1—breast cancer	3.32e-05	0.000352	CbGpPWpGaD
Lisinopril—Dry mouth—Doxorubicin—breast cancer	3.31e-05	0.000101	CcSEcCtD
Lisinopril—Vomiting—Docetaxel—breast cancer	3.31e-05	0.000101	CcSEcCtD
Lisinopril—Dyspepsia—Methotrexate—breast cancer	3.3e-05	0.0001	CcSEcCtD
Lisinopril—Rash—Docetaxel—breast cancer	3.28e-05	9.97e-05	CcSEcCtD
Lisinopril—Hypotension—Epirubicin—breast cancer	3.28e-05	9.96e-05	CcSEcCtD
Lisinopril—Dermatitis—Docetaxel—breast cancer	3.28e-05	9.96e-05	CcSEcCtD
Lisinopril—Confusional state—Doxorubicin—breast cancer	3.27e-05	9.95e-05	CcSEcCtD
Lisinopril—Decreased appetite—Methotrexate—breast cancer	3.26e-05	9.9e-05	CcSEcCtD
Lisinopril—Headache—Docetaxel—breast cancer	3.26e-05	9.9e-05	CcSEcCtD
Lisinopril—Oedema—Doxorubicin—breast cancer	3.25e-05	9.86e-05	CcSEcCtD
Lisinopril—Anaphylactic shock—Doxorubicin—breast cancer	3.25e-05	9.86e-05	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Methotrexate—breast cancer	3.24e-05	9.84e-05	CcSEcCtD
Lisinopril—Fatigue—Methotrexate—breast cancer	3.23e-05	9.82e-05	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—TUBB3—breast cancer	3.23e-05	0.000342	CbGpPWpGaD
Lisinopril—Infection—Doxorubicin—breast cancer	3.23e-05	9.8e-05	CcSEcCtD
Lisinopril—Pain—Methotrexate—breast cancer	3.21e-05	9.74e-05	CcSEcCtD
Lisinopril—Vomiting—Capecitabine—breast cancer	3.2e-05	9.73e-05	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Epirubicin—breast cancer	3.2e-05	9.71e-05	CcSEcCtD
Lisinopril—Shock—Doxorubicin—breast cancer	3.2e-05	9.71e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—breast cancer	3.18e-05	0.000337	CbGpPWpGaD
Lisinopril—Thrombocytopenia—Doxorubicin—breast cancer	3.18e-05	9.66e-05	CcSEcCtD
Lisinopril—Rash—Capecitabine—breast cancer	3.18e-05	9.65e-05	CcSEcCtD
Lisinopril—Insomnia—Epirubicin—breast cancer	3.17e-05	9.64e-05	CcSEcCtD
Lisinopril—Dermatitis—Capecitabine—breast cancer	3.17e-05	9.64e-05	CcSEcCtD
Lisinopril—Tachycardia—Doxorubicin—breast cancer	3.17e-05	9.63e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—breast cancer	3.17e-05	0.000336	CbGpPWpGaD
Lisinopril—Headache—Capecitabine—breast cancer	3.16e-05	9.59e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—breast cancer	3.16e-05	0.000335	CbGpPWpGaD
Lisinopril—Skin disorder—Doxorubicin—breast cancer	3.15e-05	9.58e-05	CcSEcCtD
Lisinopril—Paraesthesia—Epirubicin—breast cancer	3.15e-05	9.57e-05	CcSEcCtD
Lisinopril—Hyperhidrosis—Doxorubicin—breast cancer	3.14e-05	9.54e-05	CcSEcCtD
Lisinopril—Dyspnoea—Epirubicin—breast cancer	3.13e-05	9.51e-05	CcSEcCtD
Lisinopril—Somnolence—Epirubicin—breast cancer	3.12e-05	9.48e-05	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—TNF—breast cancer	3.1e-05	0.000329	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NDUFS3—breast cancer	3.1e-05	0.000328	CbGpPWpGaD
Lisinopril—Anorexia—Doxorubicin—breast cancer	3.1e-05	9.4e-05	CcSEcCtD
Lisinopril—Nausea—Docetaxel—breast cancer	3.09e-05	9.39e-05	CcSEcCtD
Lisinopril—Feeling abnormal—Methotrexate—breast cancer	3.09e-05	9.39e-05	CcSEcCtD
Lisinopril—Dyspepsia—Epirubicin—breast cancer	3.09e-05	9.38e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—breast cancer	3.08e-05	0.000327	CbGpPWpGaD
Lisinopril—Gastrointestinal pain—Methotrexate—breast cancer	3.07e-05	9.32e-05	CcSEcCtD
Lisinopril—Decreased appetite—Epirubicin—breast cancer	3.05e-05	9.27e-05	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ALB—breast cancer	3.04e-05	0.000322	CbGpPWpGaD
Lisinopril—Hypotension—Doxorubicin—breast cancer	3.03e-05	9.22e-05	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Epirubicin—breast cancer	3.03e-05	9.2e-05	CcSEcCtD
Lisinopril—Fatigue—Epirubicin—breast cancer	3.03e-05	9.19e-05	CcSEcCtD
Lisinopril—Constipation—Epirubicin—breast cancer	3e-05	9.12e-05	CcSEcCtD
Lisinopril—Pain—Epirubicin—breast cancer	3e-05	9.12e-05	CcSEcCtD
Lisinopril—Nausea—Capecitabine—breast cancer	2.99e-05	9.09e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—breast cancer	2.98e-05	0.000316	CbGpPWpGaD
Lisinopril—Urticaria—Methotrexate—breast cancer	2.98e-05	9.05e-05	CcSEcCtD
Lisinopril—Abdominal pain—Methotrexate—breast cancer	2.97e-05	9.01e-05	CcSEcCtD
Lisinopril—Body temperature increased—Methotrexate—breast cancer	2.97e-05	9.01e-05	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.96e-05	8.99e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—breast cancer	2.95e-05	0.000313	CbGpPWpGaD
Lisinopril—Insomnia—Doxorubicin—breast cancer	2.94e-05	8.92e-05	CcSEcCtD
Lisinopril—Paraesthesia—Doxorubicin—breast cancer	2.92e-05	8.86e-05	CcSEcCtD
Lisinopril—ABCB1—Metabolism—CHST9—breast cancer	2.91e-05	0.000309	CbGpPWpGaD
Lisinopril—Dyspnoea—Doxorubicin—breast cancer	2.9e-05	8.79e-05	CcSEcCtD
Lisinopril—Feeling abnormal—Epirubicin—breast cancer	2.89e-05	8.79e-05	CcSEcCtD
Lisinopril—Somnolence—Doxorubicin—breast cancer	2.89e-05	8.77e-05	CcSEcCtD
Lisinopril—Gastrointestinal pain—Epirubicin—breast cancer	2.87e-05	8.72e-05	CcSEcCtD
Lisinopril—Dyspepsia—Doxorubicin—breast cancer	2.86e-05	8.68e-05	CcSEcCtD
Lisinopril—Decreased appetite—Doxorubicin—breast cancer	2.82e-05	8.58e-05	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Doxorubicin—breast cancer	2.8e-05	8.52e-05	CcSEcCtD
Lisinopril—Fatigue—Doxorubicin—breast cancer	2.8e-05	8.51e-05	CcSEcCtD
Lisinopril—Urticaria—Epirubicin—breast cancer	2.79e-05	8.47e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—breast cancer	2.78e-05	0.000295	CbGpPWpGaD
Lisinopril—Constipation—Doxorubicin—breast cancer	2.78e-05	8.44e-05	CcSEcCtD
Lisinopril—Pain—Doxorubicin—breast cancer	2.78e-05	8.44e-05	CcSEcCtD
Lisinopril—Body temperature increased—Epirubicin—breast cancer	2.77e-05	8.43e-05	CcSEcCtD
Lisinopril—Abdominal pain—Epirubicin—breast cancer	2.77e-05	8.43e-05	CcSEcCtD
Lisinopril—Hypersensitivity—Methotrexate—breast cancer	2.76e-05	8.39e-05	CcSEcCtD
Lisinopril—ABCB1—Metabolism—COX11—breast cancer	2.76e-05	0.000293	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—RAF1—breast cancer	2.75e-05	0.000292	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—breast cancer	2.73e-05	0.00029	CbGpPWpGaD
Lisinopril—Asthenia—Methotrexate—breast cancer	2.69e-05	8.17e-05	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC2A2—breast cancer	2.69e-05	0.000285	CbGpPWpGaD
Lisinopril—Feeling abnormal—Doxorubicin—breast cancer	2.68e-05	8.13e-05	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—breast cancer	2.66e-05	0.000282	CbGpPWpGaD
Lisinopril—Gastrointestinal pain—Doxorubicin—breast cancer	2.66e-05	8.07e-05	CcSEcCtD
Lisinopril—Pruritus—Methotrexate—breast cancer	2.65e-05	8.06e-05	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ABCG2—breast cancer	2.63e-05	0.000279	CbGpPWpGaD
Lisinopril—Hypersensitivity—Epirubicin—breast cancer	2.59e-05	7.85e-05	CcSEcCtD
Lisinopril—Urticaria—Doxorubicin—breast cancer	2.58e-05	7.84e-05	CcSEcCtD
Lisinopril—Body temperature increased—Doxorubicin—breast cancer	2.57e-05	7.8e-05	CcSEcCtD
Lisinopril—Abdominal pain—Doxorubicin—breast cancer	2.57e-05	7.8e-05	CcSEcCtD
Lisinopril—Diarrhoea—Methotrexate—breast cancer	2.57e-05	7.79e-05	CcSEcCtD
Lisinopril—ABCB1—Metabolism—SHMT1—breast cancer	2.53e-05	0.000268	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CDA—breast cancer	2.53e-05	0.000268	CbGpPWpGaD
Lisinopril—Asthenia—Epirubicin—breast cancer	2.52e-05	7.65e-05	CcSEcCtD
Lisinopril—Pruritus—Epirubicin—breast cancer	2.48e-05	7.54e-05	CcSEcCtD
Lisinopril—Dizziness—Methotrexate—breast cancer	2.48e-05	7.53e-05	CcSEcCtD
Lisinopril—ABCB1—Metabolism—SLCO1B1—breast cancer	2.43e-05	0.000258	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC2A5—breast cancer	2.43e-05	0.000258	CbGpPWpGaD
Lisinopril—Diarrhoea—Epirubicin—breast cancer	2.4e-05	7.29e-05	CcSEcCtD
Lisinopril—Hypersensitivity—Doxorubicin—breast cancer	2.39e-05	7.27e-05	CcSEcCtD
Lisinopril—Vomiting—Methotrexate—breast cancer	2.38e-05	7.24e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	2.38e-05	0.000253	CbGpPWpGaD
Lisinopril—Rash—Methotrexate—breast cancer	2.36e-05	7.18e-05	CcSEcCtD
Lisinopril—Dermatitis—Methotrexate—breast cancer	2.36e-05	7.18e-05	CcSEcCtD
Lisinopril—Headache—Methotrexate—breast cancer	2.35e-05	7.14e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	2.35e-05	0.000249	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APRT—breast cancer	2.35e-05	0.000249	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—TFRC—breast cancer	2.35e-05	0.000249	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	2.34e-05	0.000248	CbGpPWpGaD
Lisinopril—Asthenia—Doxorubicin—breast cancer	2.33e-05	7.08e-05	CcSEcCtD
Lisinopril—Dizziness—Epirubicin—breast cancer	2.32e-05	7.05e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	2.32e-05	0.000246	CbGpPWpGaD
Lisinopril—Pruritus—Doxorubicin—breast cancer	2.3e-05	6.98e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	2.27e-05	0.00024	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—NCOA2—breast cancer	2.26e-05	0.00024	CbGpPWpGaD
Lisinopril—Vomiting—Epirubicin—breast cancer	2.23e-05	6.78e-05	CcSEcCtD
Lisinopril—Nausea—Methotrexate—breast cancer	2.23e-05	6.77e-05	CcSEcCtD
Lisinopril—Diarrhoea—Doxorubicin—breast cancer	2.22e-05	6.75e-05	CcSEcCtD
Lisinopril—Rash—Epirubicin—breast cancer	2.21e-05	6.72e-05	CcSEcCtD
Lisinopril—Dermatitis—Epirubicin—breast cancer	2.21e-05	6.72e-05	CcSEcCtD
Lisinopril—ABCB1—Metabolism—ESRRA—breast cancer	2.21e-05	0.000234	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ANGPTL4—breast cancer	2.21e-05	0.000234	CbGpPWpGaD
Lisinopril—Headache—Epirubicin—breast cancer	2.2e-05	6.68e-05	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC5A5—breast cancer	2.16e-05	0.000229	CbGpPWpGaD
Lisinopril—Dizziness—Doxorubicin—breast cancer	2.15e-05	6.52e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	2.15e-05	0.000227	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	2.1e-05	0.000223	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HADHB—breast cancer	2.09e-05	0.000222	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GPI—breast cancer	2.09e-05	0.000222	CbGpPWpGaD
Lisinopril—Nausea—Epirubicin—breast cancer	2.08e-05	6.33e-05	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC2A1—breast cancer	2.08e-05	0.000221	CbGpPWpGaD
Lisinopril—Vomiting—Doxorubicin—breast cancer	2.06e-05	6.27e-05	CcSEcCtD
Lisinopril—Rash—Doxorubicin—breast cancer	2.05e-05	6.22e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	2.05e-05	0.000217	CbGpPWpGaD
Lisinopril—Dermatitis—Doxorubicin—breast cancer	2.05e-05	6.21e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	2.04e-05	0.000217	CbGpPWpGaD
Lisinopril—Headache—Doxorubicin—breast cancer	2.03e-05	6.18e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	2.03e-05	0.000215	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALDH7A1—breast cancer	2e-05	0.000212	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALDH1A1—breast cancer	2e-05	0.000212	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	1.98e-05	0.00021	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.98e-05	0.000209	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.93e-05	0.000205	CbGpPWpGaD
Lisinopril—Nausea—Doxorubicin—breast cancer	1.93e-05	5.86e-05	CcSEcCtD
Lisinopril—ABCB1—Metabolism—FHL2—breast cancer	1.91e-05	0.000203	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NME1—breast cancer	1.91e-05	0.000203	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ADSL—breast cancer	1.91e-05	0.000203	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—UMPS—breast cancer	1.91e-05	0.000203	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PHGDH—breast cancer	1.91e-05	0.000203	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	1.9e-05	0.000202	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HPSE—breast cancer	1.88e-05	0.000199	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LDHB—breast cancer	1.88e-05	0.000199	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—BRIP1—breast cancer	1.88e-05	0.000199	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	1.86e-05	0.000197	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1.83e-05	0.000194	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	1.78e-05	0.000189	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ABCC1—breast cancer	1.78e-05	0.000189	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HMMR—breast cancer	1.78e-05	0.000189	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTA3—breast cancer	1.78e-05	0.000189	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARGC1B—breast cancer	1.72e-05	0.000183	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	1.71e-05	0.000182	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.69e-05	0.000179	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.64e-05	0.000174	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.64e-05	0.000174	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTA4—breast cancer	1.63e-05	0.000173	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CA9—breast cancer	1.63e-05	0.000173	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.61e-05	0.00017	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GPX2—breast cancer	1.59e-05	0.000168	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTA2—breast cancer	1.59e-05	0.000168	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GPX4—breast cancer	1.57e-05	0.000166	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SULT1A1—breast cancer	1.57e-05	0.000166	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—IDH1—breast cancer	1.53e-05	0.000162	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTA1—breast cancer	1.53e-05	0.000162	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	1.53e-05	0.000162	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	1.52e-05	0.000161	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NAT2—breast cancer	1.51e-05	0.00016	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.39e-05	0.000148	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.35e-05	0.000143	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—DPYD—breast cancer	1.33e-05	0.000141	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MED12—breast cancer	1.33e-05	0.000141	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALDOA—breast cancer	1.31e-05	0.000138	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NCOA3—breast cancer	1.27e-05	0.000134	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC2A2—breast cancer	1.26e-05	0.000133	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ABCG2—breast cancer	1.23e-05	0.000131	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CPT1A—breast cancer	1.23e-05	0.000131	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MTR—breast cancer	1.23e-05	0.000131	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HPGDS—breast cancer	1.21e-05	0.000128	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HBA1—breast cancer	1.2e-05	0.000127	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTT1—breast cancer	1.17e-05	0.000124	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ACHE—breast cancer	1.17e-05	0.000124	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.14e-05	0.000121	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP17A1—breast cancer	1.11e-05	0.000118	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ENO1—breast cancer	1.1e-05	0.000117	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTGS1—breast cancer	1.1e-05	0.000117	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP2D6—breast cancer	1.08e-05	0.000114	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NCOA2—breast cancer	1.06e-05	0.000112	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	1.03e-05	0.000109	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—FASN—breast cancer	1.03e-05	0.000109	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—BCHE—breast cancer	1.02e-05	0.000108	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC5A5—breast cancer	1.01e-05	0.000107	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NQO1—breast cancer	9.75e-06	0.000103	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC2A1—breast cancer	9.75e-06	0.000103	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP3A4—breast cancer	9.51e-06	0.000101	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP1B1—breast cancer	9.35e-06	9.91e-05	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	9.3e-06	9.86e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HSP90AA1—breast cancer	9.17e-06	9.72e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NCOA1—breast cancer	8.92e-06	9.45e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP19A1—breast cancer	8.79e-06	9.32e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—STK11—breast cancer	8.79e-06	9.32e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—COMT—breast cancer	8.17e-06	8.66e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTP1—breast cancer	8.13e-06	8.62e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HMOX1—breast cancer	8.02e-06	8.5e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ITPR1—breast cancer	8e-06	8.48e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TYMS—breast cancer	7.56e-06	8.01e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NCOR1—breast cancer	7.47e-06	7.92e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PLA2G4A—breast cancer	7.47e-06	7.92e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTM1—breast cancer	7.47e-06	7.92e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GPX1—breast cancer	7.16e-06	7.59e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP1A1—breast cancer	7.08e-06	7.51e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ERCC2—breast cancer	7.03e-06	7.45e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MTHFR—breast cancer	6.6e-06	7e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CAV1—breast cancer	6.09e-06	6.46e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CG—breast cancer	5.55e-06	5.88e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CD—breast cancer	4.88e-06	5.17e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALB—breast cancer	4.81e-06	5.11e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NOS3—breast cancer	4.61e-06	4.88e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CB—breast cancer	4.25e-06	4.51e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTGS2—breast cancer	4.21e-06	4.47e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTEN—breast cancer	3.67e-06	3.9e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CA—breast cancer	2.59e-06	2.75e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AKT1—breast cancer	2.12e-06	2.24e-05	CbGpPWpGaD
